The UC Davis Psychedelic Summit brought together national experts to explore what the rapidly evolving field of psychedelics and neurotherapeutics may mean for neuropsychiatric and neurodegenerative diseases. These new treatment types may hold promise for anxiety, depression, substance use, obsessive-compulsive and post-traumatic stress disorders, among others. The event was hosted by the UC Davis Department of Psychiatry and Behavioral Sciences, the UC Davis Institute for Psychedelics and Neurotherapeutics, and the UC Davis Behavioral Health Center for Excellence.
Watch more lectures from this conference: https://youtube.com/playlist?list=PLM7qvIv8N9RuTdLd7xOa7FoTM3bVsahte
Learn more about the Psychedelic Summit at UC Davis: https://health.ucdavis.edu/news/headlines/top-psychedelic-researchers-featured-in-new-video-series/2023/06
UC Davis Department of Psychiatry and Behavioral Sciences: https://health.ucdavis.edu/psychiatry/
UC Davis Institute for Psychedelics and Neurotherapeutics: https://neurotherapeutics.ucdavis.edu/
UC Davis Behavioral Health Center for Excellence: https://behavioralhealth.ucdavis.edu
See the latest news from UC Davis Health: https://health.ucdavis.edu/newsroom
0:00 Introduction
1:24 Studying magic mushrooms
6:00 Challenges of psychedelic trials
9:47 Current approach to psychedelic psychotherapy
12:05 Psychotherapy delivery model
16:09 Psilocybin assisted group therapy for demoralization in long-term AIDS surivivors
23:54 "Hype + Hope" of psychedelics in medicine
30:26 The challenge of masking
35:40 Suggestions for improving trials
36:21 Safety of psilocybin trials
44:04 Does psilocybin increase risk for psychosis/mania?
48:20 Summary of psilocybin research
49:18 Questions from the audience
#psilocybin #psychedelic #research #ucdavis
" />
